Skip to main content

Cancer Biomarkers

Promotes research to identify, develop, and validate biological markers for early cancer detection, risk prediction, and prevention. Supports development of collaborative databases and informatics systems, advancement of new technologies, and refinement of existing technologies.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Evans Williams, Felicia, M.B.A. felicia.evanslong@nih.gov 240-276-5076	5E636	Program Analyst \| Cancer Biomarkers
	Fu, Sidney, M.D. sidney.fu@nih.gov 240-276-6669	5E134	Program Officer \| Cancer Biomarkers
	Hodges, Nicholas, Ph.D. nick.hodges@nih.gov 240-276-7844	5E616	Program Officer \| Cancer Biomarkers
	Kohaar, Indu, Ph.D., M.Phil., M.Sc. indu.kohaar@nih.gov 240-620-0875	5E612	Program Officer \| Cancer Biomarkers
	Krueger, Karl, Ph.D. [V] karl.krueger@nih.gov		Volunteer \| Cancer Biomarkers
	Marquez, Guillermo, Ph.D. guillermo.marquez@nih.gov 240-276-7035	5E132	Program Officer \| Cancer Biomarkers
	Orr, Susan susan.orr@nih.gov 240-276-5001	5E626	Program Support Assistant \| Cancer Biomarkers
	Patriotis, Christos, Ph.D., M.Sc. christos.patriotis@nih.gov 240-276-7134	5E614	Deputy Chief \| Cancer Biomarkers
	Petruzzelli, Angie angie.petruzzelli@nih.gov 240-276-5076	5E624	Program Support Assistant \| Cancer Biomarkers
	Srivastava, Sudhir, Ph.D., M.P.H. sudhir.srivastava@nih.gov 240-276-7028	5E136	Chief \| Cancer Biomarkers
	Villanueva, Juan Miguel juan.villanueva@nih.gov	5E630	Program Analyst \| Cancer Biomarkers
	Wang, Wendy, Ph.D., M.Sc. wendy.wang@nih.gov 240-276-7117	5E566	Program Officer \| Cancer Biomarkers
	Young, Matthew, Ph.D. matthew.young@nih.gov 240-276-5846	5E610	Program Officer \| Cancer Biomarkers

Grants

PI Name	PI Organization	Title Sort descending	Grant Number	Program Official
Punnen, Sanoj	University Of Miami School Of Medicine United States	The Rigor and Clinical Utility of PSMA Enriched Extracellular Vesicles for Prostate Cancer Detection	5R01CA272766-03	Matthew Young, Ph.D.
Zhou, Xianghong Jasmine	University Of California Los Angeles United States	The UCLA Center in Early Detection of Liver Cancer	5U01CA230705-08	Sidney Fu, M.D.
Hoshida, Yujin	Ut Southwestern Medical Center United States	Therapeutic modulation of a proteomic HCC risk signature with statins in patients with liver cirrhosis	4U01CA288375-03	Sidney Fu, M.D.
Li, Bo	Children'S Hosp Of Philadelphia United States	Tracking Peripheral T-Cell Repertoire Changes for Preoperative and Early Ovarian Cancer Diagnosis	5R01CA258524-06	Christos Patriotis, Ph.D., M.Sc.
Grady, William Mallory	Fred Hutchinson Cancer Center United States	Understanding adenoma progression: Interplay among tissue microenvironment, clonal architecture, and gut microbiome	3U54CA274374-04S2	Christos Patriotis, Ph.D., M.Sc.
Lokshin, Anna E	University Of Pittsburgh At Pittsburgh United States	Urine and serum biomarkers for early diagnosis and risk assessment of pancreatic cancer	5R01CA254036-05	Matthew Young, Ph.D.
Torres, Keila Enitt	University Of Tx Md Anderson Can Ctr United States	Use of Noninvasive Biomarkers and Advanced MRI for early detection of NF1-associated MPNSTs	5R01CA285980-02	Guillermo Marquez, Ph.D.
Goggins, Michael G.	Johns Hopkins University United States	Using markers to improve pancreatic cancer screening and surveillance: a multi-center study	5U01CA210170-09	Matthew Young, Ph.D.
Kirkwood, Kimberly Saunders	University Of California, San Francisco United States	Using microvolumetric cyst fluid proteolysis for early detection of pancreatic cancer	5U01CA282269-02	Matthew Young, Ph.D.
Permuth, Jennifer B	H. Lee Moffitt Cancer Ctr & Res Inst United States	Using Radiogenomics to Noninvasively Predict the Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Uncover Hidden Biology	5R37CA229810-07	Matthew Young, Ph.D.
Markowitz, Sanford D.	Case Western Reserve University United States	Validation of Biomarkers for predicting Barrett's esophagus that will or will not: i) progress towards cancer, or ii) recur after ablation	5U01CA271867-04	Matthew Young, Ph.D.
Brand, Randall	University Of Pittsburgh At Pittsburgh United States	Validation of biomarkers for risk prediction and early diagnosis of Pancreatic Adenocarcinoma	5U01CA200466-08	Matthew Young, Ph.D.
Sears, Rosalie C	Oregon Health & Science University United States	Validation of novel imaging and molecular tests for early detection of pancreatic cancer through risk-stratified community engagement programs	5U01CA278923-03	Matthew Young, Ph.D.